Clinical trials
Completed Cushing Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corcept Therapeutics | 11 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 9 |
| National Institute of Mental Health (NIMH) | 3 |
| Cortendo AB | 2 |
| Columbia University | 1 |
| Crinetics Pharmaceuticals Inc. | 1 |
| National Center for Research Resources (NCRR) | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Novartis Pharmaceuticals | 1 |
| RECORDATI GROUP | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cushing Syndrome | 32 |
| ACTH Syndrome, Ectopic | 9 |
| Pituitary ACTH Hypersecretion | 8 |
| Diabetes Mellitus, Type 2 | 5 |
| Adrenal Cortex Neoplasms | 4 |
| Adrenocortical Hyperfunction | 4 |
| Endocrine System Diseases | 4 |
| Hypertension | 4 |
| Pituitary Diseases | 3 |
| Adrenocortical Carcinoma | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.